Your session is about to expire
← Back to Search
CDS Tool Access for High Blood Pressure (COHERE Trial)
N/A
Waitlist Available
Led By Laura Gottlieb, MD, MPH
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
COHERE Trial Summary
This trial will develop and test tools to help doctors identify and treat patients based on social risks like poverty or lack of transportation. The goal is to see if this leads to better outcomes for conditions like hypertension and diabetes.
Who is the study for?
This trial is for clinics that joined OCHIN by July 1, 2021, have done over 200 social risk screenings in the past year, and provide primary care. Clinics that took part in the pilot study, serve prison populations or are school-based health centers cannot participate.Check my eligibility
What is being tested?
The COHERE study is testing a new tool called CDS which shows patient's social risks to healthcare teams so they can adjust treatment plans. The goal is to see if this leads to better control of high blood pressure and type 2 diabetes.See study design
What are the potential side effects?
Since this trial involves a decision support tool rather than medication, there aren't direct physical side effects like with drugs. However, there may be impacts on clinic workflow or data management processes.
COHERE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
diabetes control
hypertension control
Secondary outcome measures
SDH z-codes added to problem list and/or visit list
completion of medication adherence documentation
completion of social risk screening
COHERE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Intervention clinics will have the CDS tools turned on in their EHR.
Group II: Control ArmActive Control1 Intervention
Control clinics will not receive an intervention.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoOTHER
2,500 Previous Clinical Trials
15,236,421 Total Patients Enrolled
Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,113,778 Total Patients Enrolled
OCHIN, Inc.OTHER
21 Previous Clinical Trials
8,185,272 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The clinic offers healthcare services to people in prison.
Research Study Groups:
This trial has the following groups:- Group 1: Control Arm
- Group 2: Intervention Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still an opportunity for individuals to join this research endeavor?
"Evidently, this study is not currently seeking participants. Initially posted on September 12th 2022 and last refreshed on November 16th 2022, it appears that there are other 1 502 trials which are actively recruiting patients at the present moment in time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger